UTHR logo

United Therapeutics (UTHR) Retained earnings

annual retained earnings:

$7.22B+$1.20B(+19.83%)
December 31, 2024

Summary

  • As of today (May 25, 2025), UTHR annual retained earnings is $7.22 billion, with the most recent change of +$1.20 billion (+19.83%) on December 31, 2024.
  • During the last 3 years, UTHR annual retained earnings has risen by +$2.91 billion (+67.37%).
  • UTHR annual retained earnings is now at all-time high.

Performance

UTHR Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRbalance sheet metrics

quarterly retained earnings:

$7.54B+$322.20M(+4.46%)
March 31, 2025

Summary

  • As of today (May 25, 2025), UTHR quarterly retained earnings is $7.54 billion, with the most recent change of +$322.20 million (+4.46%) on March 31, 2025.
  • Over the past year, UTHR quarterly retained earnings has increased by +$1.21 billion (+19.12%).
  • UTHR quarterly retained earnings is now at all-time high.

Performance

UTHR quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

UTHR Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.8%+19.1%
3 y3 years+67.4%+65.6%
5 y5 years+117.2%+117.9%

UTHR Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+67.4%at high+65.6%
5 y5-yearat high+117.2%at high+117.9%
alltimeall timeat high+3788.8%at high+3917.3%

UTHR Retained earnings History

DateAnnualQuarterly
Mar 2025
-
$7.54B(+4.5%)
Dec 2024
$7.22B(+19.8%)
$7.22B(+4.4%)
Sep 2024
-
$6.92B(+4.7%)
Jun 2024
-
$6.61B(+4.4%)
Mar 2024
-
$6.33B(+5.1%)
Dec 2023
$6.03B(+19.5%)
$6.03B(+3.7%)
Sep 2023
-
$5.81B(+4.8%)
Jun 2023
-
$5.54B(+4.9%)
Mar 2023
-
$5.28B(+4.8%)
Dec 2022
$5.04B(+16.9%)
$5.04B(+2.7%)
Sep 2022
-
$4.91B(+5.1%)
Jun 2022
-
$4.67B(+2.5%)
Mar 2022
-
$4.55B(+5.6%)
Dec 2021
$4.32B(+12.4%)
$4.32B(+2.7%)
Sep 2021
-
$4.20B(+4.0%)
Jun 2021
-
$4.04B(+4.5%)
Mar 2021
-
$3.87B(+0.7%)
Dec 2020
$3.84B(+15.5%)
$3.84B(+2.6%)
Sep 2020
-
$3.74B(+4.8%)
Jun 2020
-
$3.57B(+3.1%)
Mar 2020
-
$3.46B(+4.1%)
Dec 2019
$3.33B(-3.2%)
$3.33B(+1.6%)
Sep 2019
-
$3.27B(+4.2%)
Jun 2019
-
$3.14B(+7.0%)
Mar 2019
-
$2.94B(-14.5%)
Dec 2018
$3.43B(+20.7%)
$3.43B(+1.9%)
Sep 2018
-
$3.37B(+3.3%)
Jun 2018
-
$3.26B(+5.6%)
Mar 2018
-
$3.09B(+8.6%)
Dec 2017
$2.85B(+16.9%)
$2.85B(+0.7%)
Sep 2017
-
$2.83B(+10.8%)
Jun 2017
-
$2.55B(-2.1%)
Mar 2017
-
$2.61B(+7.1%)
Dec 2016
$2.43B(+41.5%)
$2.43B(+4.7%)
Sep 2016
-
$2.32B(+7.5%)
Jun 2016
-
$2.16B(+10.5%)
Mar 2016
-
$1.96B(+13.7%)
Dec 2015
$1.72B(+61.0%)
$1.72B(+6.5%)
Sep 2015
-
$1.62B(+40.4%)
Jun 2015
-
$1.15B(+9.4%)
Mar 2015
-
$1.05B(-1.6%)
Dec 2014
$1.07B(+46.7%)
$1.07B(+12.2%)
Sep 2014
-
$952.18M(-2.6%)
Jun 2014
-
$977.42M(+12.9%)
Mar 2014
-
$865.56M(+18.9%)
Dec 2013
$728.04M(+31.5%)
$728.04M(-4.0%)
Sep 2013
-
$758.35M(+9.0%)
Jun 2013
-
$695.67M(+13.0%)
Mar 2013
-
$615.80M(+11.3%)
Dec 2012
$553.48M(+122.2%)
$553.48M(+17.7%)
Sep 2012
-
$470.23M(+19.9%)
Jun 2012
-
$392.11M(+22.6%)
Mar 2012
-
$319.80M(+28.4%)
DateAnnualQuarterly
Dec 2011
$249.04M(+699.0%)
$249.04M(+21.0%)
Sep 2011
-
$205.85M(+69.5%)
Jun 2011
-
$121.45M(+155.4%)
Mar 2011
-
$47.56M(+52.6%)
Dec 2010
$31.17M(-141.7%)
$31.17M(+44.1%)
Sep 2010
-
$21.63M(-219.4%)
Jun 2010
-
-$18.11M(-67.6%)
Mar 2010
-
-$55.82M(-25.3%)
Dec 2009
-$74.75M(-20.4%)
-$74.75M(+5.1%)
Sep 2009
-
-$71.14M(-14.4%)
Jun 2009
-
-$83.07M(+4.1%)
Mar 2009
-
-$79.78M(-15.1%)
Dec 2008
-$93.93M(+336.8%)
-$93.93M(-657.3%)
Sep 2008
-
$16.86M(+298.3%)
Jun 2008
-
$4.23M(-141.9%)
Mar 2008
-
-$10.10M(-53.0%)
Dec 2007
-$21.50M(-48.0%)
-$21.50M(-8.5%)
Sep 2007
-
-$23.49M(-38.7%)
Jun 2007
-
-$38.34M(-13.2%)
Mar 2007
-
-$44.14M(+6.7%)
Dec 2006
-$41.36M(-64.1%)
-$41.36M(-57.3%)
Sep 2006
-
-$96.87M(-8.0%)
Jun 2006
-
-$105.34M(-6.8%)
Mar 2006
-
-$113.02M(-2.0%)
Dec 2005
-$115.33M(-36.1%)
-$115.33M(-20.3%)
Sep 2005
-
-$144.74M(-9.8%)
Jun 2005
-
-$160.50M(-7.1%)
Mar 2005
-
-$172.68M(-4.2%)
Dec 2004
-$180.34M(-7.9%)
-$180.34M(-3.7%)
Sep 2004
-
-$187.23M(-3.2%)
Jun 2004
-
-$193.50M(-2.1%)
Mar 2004
-
-$197.64M(+0.9%)
Dec 2003
-$195.79M(+5.4%)
-$195.79M(+1.7%)
Sep 2003
-
-$192.57M(+0.7%)
Jun 2003
-
-$191.23M(+1.3%)
Mar 2003
-
-$188.84M(+1.6%)
Dec 2002
-$185.82M(+14.6%)
-$185.82M(+1.4%)
Sep 2002
-
-$183.22M(+7.1%)
Jun 2002
-
-$171.03M(+1.9%)
Mar 2002
-
-$167.85M(+3.5%)
Dec 2001
-$162.17M(+29.9%)
-$162.17M(+4.8%)
Sep 2001
-
-$154.74M(+6.8%)
Jun 2001
-
-$144.93M(+7.9%)
Mar 2001
-
-$134.28M(+7.5%)
Dec 2000
-$124.88M(+153.3%)
-$124.88M(+34.3%)
Sep 2000
-
-$93.01M(+8.2%)
Jun 2000
-
-$86.00M(+50.4%)
Mar 2000
-
-$57.19M(+16.0%)
Dec 1999
-$49.30M(+212.0%)
-$49.30M(+21.7%)
Sep 1999
-
-$40.50M(+18.8%)
Jun 1999
-
-$34.10M(+21.8%)
Mar 1999
-
-$28.00M
Dec 1998
-$15.80M
-

FAQ

  • What is United Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for United Therapeutics?
  • What is United Therapeutics annual retained earnings year-on-year change?
  • What is United Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for United Therapeutics?
  • What is United Therapeutics quarterly retained earnings year-on-year change?

What is United Therapeutics annual retained earnings?

The current annual retained earnings of UTHR is $7.22B

What is the all time high annual retained earnings for United Therapeutics?

United Therapeutics all-time high annual retained earnings is $7.22B

What is United Therapeutics annual retained earnings year-on-year change?

Over the past year, UTHR annual retained earnings has changed by +$1.20B (+19.83%)

What is United Therapeutics quarterly retained earnings?

The current quarterly retained earnings of UTHR is $7.54B

What is the all time high quarterly retained earnings for United Therapeutics?

United Therapeutics all-time high quarterly retained earnings is $7.54B

What is United Therapeutics quarterly retained earnings year-on-year change?

Over the past year, UTHR quarterly retained earnings has changed by +$1.21B (+19.12%)
On this page